Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
Senseonics Holdings Inc (NYSE:SENS) stock has reached a new 52-week high, touching $1.21, as the medical technology company experiences a significant surge in its market valuation. With a market ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term ...
According to Benzinga Pro, Senseonics Holdings's peer group average for short interest as a percentage of float is 5.65%, ...
Senseonics Holdings Inc (SENS)股价创下新的52周高点,触及$1.21。这家医疗技术公司的市值达到7.02亿美元,日均交易量为1,360万股,显示出显著的市场估值增长。年初至今,该公司股价已上涨110%。在过去一年中,这家专注于开发糖尿病管理血糖监测系统的公司,股价增长了97.78%。 这一显著的上升趋势反映了投资者对公司发展前景的信心,以及其在糖尿病护理市场扩大市场份 ...
GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term ...
Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results